# Malady Kyle: insider transactions

SEC CIK 1760581. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-28.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Verizon Communications Inc](/companies/vz.md) | EVP and Group CEO-VZ Business, Officer | 2 | 2026-10-22 | 2026-10-27 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-27 | [Verizon Communications Inc](/companies/vz.md) | Sale (S) | 1,100 | $43.00 | $47.3k | [Form 4](/filings/0001760581-26-000075.md) |
| 2026-10-22 | [Verizon Communications Inc](/companies/vz.md) | Grant or award (A), derivative | 134.656 | $12.91 | $1.7k | [Form 4](/filings/0001760581-26-000073.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 04:59 ET. No prices; not investment advice.